temozolomide has been researched along with Deficiency, Vitamin B 12 in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report pancytopenia caused by temozolomide, a second-generation alkylating agent." | 7.77 | Another cause of pancytopenia in a patient receiving temozolomide. ( Camci, C; Dirier, A; Kalender, ME; Pehlivan, Y; Sevinc, A; Turkbeyler, IH, 2011) |
| "To report pancytopenia caused by temozolomide, a second-generation alkylating agent." | 3.77 | Another cause of pancytopenia in a patient receiving temozolomide. ( Camci, C; Dirier, A; Kalender, ME; Pehlivan, Y; Sevinc, A; Turkbeyler, IH, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pehlivan, Y | 1 |
| Sevinc, A | 1 |
| Turkbeyler, IH | 1 |
| Dirier, A | 1 |
| Kalender, ME | 1 |
| Camci, C | 1 |
1 other study available for temozolomide and Deficiency, Vitamin B 12
| Article | Year |
|---|---|
Another cause of pancytopenia in a patient receiving temozolomide.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Female; Glioblastoma; Humans; Pancytopenia; Risk Fac | 2011 |